Literature DB >> 19506225

Characterization of DCTN1 genetic variability in neurodegeneration.

C Vilariño-Güell1, C Wider, A I Soto-Ortolaza, S A Cobb, J M Kachergus, B H Keeling, J C Dachsel, M M Hulihan, D W Dickson, Z K Wszolek, R J Uitti, N R Graff-Radford, B F Boeve, K A Josephs, B Miller, K B Boylan, K Gwinn, C H Adler, J O Aasly, F Hentati, A Destée, A Krygowska-Wajs, M-C Chartier-Harlin, O A Ross, R Rademakers, M J Farrer.   

Abstract

OBJECTIVE: Recently, mutations in DCTN1 were found to cause Perry syndrome, a parkinsonian disorder with TDP-43-positive pathology. Previously, mutations in DCTN1 were identified in a family with lower motor neuron disease, in amyotrophic lateral sclerosis (ALS), and in a family with ALS/frontotemporal dementia (FTD), suggesting a central role for DCTN1 in neurodegeneration.
METHODS: In this study we sequenced all DCTN1 exons and exon-intron boundaries in 286 samples diagnosed with Parkinson disease (PD), frontotemporal lobar degeneration (FTLD), or ALS.
RESULTS: This analysis revealed 36 novel variants (9 missense, 5 silent, and 22 noncoding). Segregation analysis in families and association studies in PD, FTLD, and ALS case-control series did not identify any variants segregating with disease or associated with increased disease risk.
CONCLUSIONS: This study suggests that pathogenic mutations in DCTN1 are rare and do not play a common role in the development of Parkinson disease, frontotemporal lobar degeneration, or amyotrophic lateral sclerosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19506225      PMCID: PMC2692178          DOI: 10.1212/WNL.0b013e3181a92c4c

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

1.  Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS.

Authors:  C Münch; R Sedlmeier; T Meyer; V Homberg; A D Sperfeld; A Kurt; J Prudlo; G Peraus; C O Hanemann; G Stumm; A C Ludolph
Journal:  Neurology       Date:  2004-08-24       Impact factor: 9.910

Review 2.  Dynactin.

Authors:  Trina A Schroer
Journal:  Annu Rev Cell Dev Biol       Date:  2004       Impact factor: 13.827

3.  Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD.

Authors:  Christoph Münch; Angela Rosenbohm; Anne-Dorte Sperfeld; Ingo Uttner; Sven Reske; Bernd J Krause; Reinhard Sedlmeier; Thomas Meyer; Clemens O Hanemann; Gabriele Stumm; Albert C Ludolph
Journal:  Ann Neurol       Date:  2005-11       Impact factor: 10.422

4.  CLIP170 autoinhibition mimics intermolecular interactions with p150Glued or EB1.

Authors:  Ikuko Hayashi; Michael J Plevin; Mitsuhiko Ikura
Journal:  Nat Struct Mol Biol       Date:  2007-09-09       Impact factor: 15.369

5.  A microtubule-binding domain in dynactin increases dynein processivity by skating along microtubules.

Authors:  Tara L Culver-Hanlon; Stephanie A Lex; Andrew D Stephens; Nicholas J Quintyne; Stephen J King
Journal:  Nat Cell Biol       Date:  2006-02-12       Impact factor: 28.824

Review 6.  Axonal transport and neurodegenerative disease.

Authors:  Erica Chevalier-Larsen; Erika L F Holzbaur
Journal:  Biochim Biophys Acta       Date:  2006-04-19

7.  Mutant dynactin in motor neuron disease.

Authors:  Imke Puls; Catherine Jonnakuty; Bernadette H LaMonte; Erika L F Holzbaur; Mariko Tokito; Eric Mann; Mary Kay Floeter; Kimberly Bidus; Dennis Drayna; Shin J Oh; Robert H Brown; Christy L Ludlow; Kenneth H Fischbeck
Journal:  Nat Genet       Date:  2003-03-10       Impact factor: 38.330

8.  Lrrk2 pathogenic substitutions in Parkinson's disease.

Authors:  Ignacio F Mata; Jennifer M Kachergus; Julie P Taylor; Sarah Lincoln; Jan Aasly; Timothy Lynch; Mary M Hulihan; Stephanie A Cobb; Ruey-Meei Wu; Chin-Song Lu; Carlos Lahoz; Zbigniew K Wszolek; Matthew J Farrer
Journal:  Neurogenetics       Date:  2005-09-17       Impact factor: 2.660

9.  Distal spinal and bulbar muscular atrophy caused by dynactin mutation.

Authors:  Imke Puls; Shin J Oh; Charlotte J Sumner; Karen E Wallace; Mary Kay Floeter; Eric A Mann; William R Kennedy; Gwen Wendelschafer-Crabb; Alexander Vortmeyer; Richard Powers; Kimberly Finnegan; Erika L F Holzbaur; Kenneth H Fischbeck; Christy L Ludlow
Journal:  Ann Neurol       Date:  2005-05       Impact factor: 10.422

10.  A motor neuron disease-associated mutation in p150Glued perturbs dynactin function and induces protein aggregation.

Authors:  Jennifer R Levy; Charlotte J Sumner; Juliane P Caviston; Mariko K Tokito; Srikanth Ranganathan; Lee A Ligon; Karen E Wallace; Bernadette H LaMonte; George G Harmison; Imke Puls; Kenneth H Fischbeck; Erika L F Holzbaur
Journal:  J Cell Biol       Date:  2006-02-27       Impact factor: 10.539

View more
  25 in total

Review 1.  Familial Amyotrophic Lateral Sclerosis.

Authors:  Kevin Boylan
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

2.  Microtubule defects & Neurodegeneration.

Authors:  Fiona J Baird; Craig L Bennett
Journal:  J Genet Syndr Gene Ther       Date:  2013-12-06

Review 3.  DCTN1-related neurodegeneration: Perry syndrome and beyond.

Authors:  Takuya Konno; Owen A Ross; Hélio A G Teive; Jarosław Sławek; Dennis W Dickson; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2017-06-12       Impact factor: 4.891

4.  Combining Structure-Function and Single-Molecule Studies on Cytoplasmic Dynein.

Authors:  Lu Rao; Maren Hülsemann; Arne Gennerich
Journal:  Methods Mol Biol       Date:  2018

Review 5.  Mechanism and regulation of cytoplasmic dynein.

Authors:  Michael A Cianfrocco; Morgan E DeSantis; Andres E Leschziner; Samara L Reck-Peterson
Journal:  Annu Rev Cell Dev Biol       Date:  2015-09-30       Impact factor: 13.827

6.  Perry Syndrome: A Distinctive Type of TDP-43 Proteinopathy.

Authors:  Takayasu Mishima; Shunsuke Koga; Wen-Lang Lin; Koji Kasanuki; Monica Castanedes-Casey; Zbigniew K Wszolek; Shin J Oh; Yoshio Tsuboi; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2017-08-01       Impact factor: 3.685

7.  The dynactin p150 subunit: cell biology studies of sequence changes found in ALS/MND and Parkinsonian syndromes.

Authors:  Marianne Stockmann; Marie Meyer-Ohlendorf; Kevin Achberger; Stefan Putz; Maria Demestre; Haishan Yin; Corinna Hendrich; Leonhard Linta; Jutta Heinrich; Cornelia Brunner; Christian Proepper; Georges F Kuh; Bernd Baumann; Torben Langer; Birgit Schwalenstöcker; Kerstin E Braunstein; Christine von Arnim; Stephan Schneuwly; Thomas Meyer; Philip C Wong; Tobias M Boeckers; Albert C Ludolph; Stefan Liebau
Journal:  J Neural Transm (Vienna)       Date:  2012-11-11       Impact factor: 3.575

8.  Identification of FUS p.R377W in essential tremor.

Authors:  A Rajput; A H Rajput; M L Rajput; M Encarnacion; C Q Bernales; J P Ross; M J Farrer; C Vilariño-Güell
Journal:  Eur J Neurol       Date:  2013-07-03       Impact factor: 6.089

9.  DNAJC13 mutations in Parkinson disease.

Authors:  Carles Vilariño-Güell; Alex Rajput; Austen J Milnerwood; Brinda Shah; Chelsea Szu-Tu; Joanne Trinh; Irene Yu; Mary Encarnacion; Lise N Munsie; Lucia Tapia; Emil K Gustavsson; Patrick Chou; Igor Tatarnikov; Daniel M Evans; Frederick T Pishotta; Mattia Volta; Dayne Beccano-Kelly; Christina Thompson; Michelle K Lin; Holly E Sherman; Heather J Han; Bruce L Guenther; Wyeth W Wasserman; Virginie Bernard; Colin J Ross; Silke Appel-Cresswell; A Jon Stoessl; Christopher A Robinson; Dennis W Dickson; Owen A Ross; Zbigniew K Wszolek; Jan O Aasly; Ruey-Meei Wu; Faycal Hentati; Rachel A Gibson; Peter S McPherson; Martine Girard; Michele Rajput; Ali H Rajput; Matthew J Farrer
Journal:  Hum Mol Genet       Date:  2013-11-11       Impact factor: 6.150

10.  Frontotemporal dementia in a Brazilian kindred with the c9orf72 mutation.

Authors:  Leonel T Takada; Maria Lucia V Pimentel; Mariely Dejesus-Hernandez; Jamie C Fong; Jennifer S Yokoyama; Anna Karydas; Marie-Pierre Thibodeau; Nicola J Rutherford; Matthew C Baker; Catherine Lomen-Hoerth; Rosa Rademakers; Bruce L Miller
Journal:  Arch Neurol       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.